Switch to
More onapp

How to use scorecard? Learn more

Mangalam Drugs and Organics Ltd

MANGALAM
Health CarePharmaceuticals
SmallcapWith a market cap of ₹174 cr, stock is ranked 2,585
High RiskStock is 3.40x as volatile as Nifty
110.220.14 (-0.13%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹174 cr, stock is ranked 2,585
High RiskStock is 3.40x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
PB RatioPB Ratio
1.28
Dividend YieldDiv. Yield
Sector PESector PE
51.35
Sector PBSector PB
6.54
Sector Div YldSctr Div Yld
0.51%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Mangalam Drugs and Organics Limited is engaged in the manufacturing of drugs, medicines and allied products. The Company also manufactures active pharma ingredients (API), intermediates and specialty chemicals.

Financial TrendFinancial statements 

2024368.69-9.08
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Board Meeting Intimation 
Announced OnNov 8, 2024

MANGALAM DRUGS AND ORGANICS LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2024 . | Download

MANGALAM DRUGS AND ORGANICS LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2024 . | Download

Certificate under SEBI (Depositories and Participants) Regulations, 2018 
Announced OnOct 17, 2024

Mangalam Drugs And Organics Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 | Download

Mangalam Drugs And Organics Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 | Download

Cash Dividend 
Ex. DateDec 21, 2017

Interim • Div/Share: ₹ 0.5

See all events